Skip to content

Jacob A. Donoghue, M.D., Ph.D.

Chief Executive Officer at Beacon Biosignals.

Earliest Form D on file: Apr 2026

Filed Apr 15, 2026

Beacon Biosignals

EEG analytics and home sleep tests for drug trials

Healthcare, Boston MA

Signed as Chief Executive Officer

$103.3M

sold of $103.3M offered

Form D

Network

At Beacon Biosignals

4 people